Sobi: Wills Hughes-Wilson appointed Vice President Government Affairs & Policy

02-Feb-2012 - Sweden

Wills Hughes-Wilson has been appointed Vice President, Government Affairs & Policy with responsibility for Sobi's contacts with all stakeholders in the health policy area.

Wills comes from Genzyme Corporation, now part of the French Sanofi Group, where she was Vice President Health/Market Access Policy, Europe. She joined Genzyme in 2005. Prior to Genzyme she was Executive Director of Emerging Biopharmaceutical Enterprises (EBE), a specialized group of the European Federation of Pharmaceuticals Industries & Associations (EFPIA) representing the interest of biotechnology companies in Europe. She has also worked in the animal health/veterinary medicines industry and at Ernst & Young Consulting.

Will Hughes Wilson, born in 1971, is an Honors graduate in Law from University of Durham in the UK. She will report to CEO Geoffrey McDonough and will be a member of the Executive Leadership Team, based in Brussels. She will assume her position in February 2012.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances